logo
[breadcrumb_custom]

Tag: Cardiff Oncology Inc.

PNC Stock
Finance

Cardiff Oncology Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects

Cardiff Oncology Inc ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $6.42 on 03/25/24, while the lowest value for the same period was recorded at $0.94 on 11/10/23. 52-week price history of CRDF Stock A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Cardiff Oncology Inc’s current trading price is -28.50% away from its 52-week high, while its distance from the 52-week low is 388.30%. The stock’s price range during this period has spanned from $0.94 to $6.42. In the Healthcare sector, the

ELVT Stock
Industry

CRDF’s Stock Dilemma: Cardiff Oncology Inc’s Market Performance and Outlook

In terms of market performance, Cardiff Oncology Inc had a somewhat regular. The highest value for the stock in the past year was $6.42 on 03/25/24, while the lowest value was $0.94 on 11/10/23. 52-week price history of CRDF Stock A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Cardiff Oncology Inc’s current trading price is -8.26% away from its 52-week high, while its distance from the 52-week low is 526.60%. The stock’s price range during this period has fluctuated between $0.94 and $6.42. Shares of the company, which

News

CRDF’s Stock Market Puzzle: Piecing Together 2023’s Performance

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price increase of 283.11%. However, over the past six months, we’ve seen a weaker performance of 342.97%. The price of CRDF fallen by 55.34% over the last 30 days. And in the last five days, it has fallen by -1.39%. Cardiff Oncology Inc’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $6.42 on 03/25/24, with the lowest value being $0.94

Stock

Cardiff Oncology Inc Inc. (CRDF) Price Performance: The Role of Supply and Demand

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The index has shown a price gain of 299.32% this year. Over the last six months, there has been a weaker performance of 267.08%. The price of CRDF fallen by 253.89% during the last 30 days period. For the last 5-days stocks have improved 14.31%. Cardiff Oncology Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $6.11 on 03/26/24, and the lowest price during the same period

Industry

Cardiff Oncology Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects

Cardiff Oncology Inc ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $6.06 on 03/22/24, while the lowest value for the same period was recorded at $0.94 on 11/10/23. 52-week price history of CRDF Stock A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Cardiff Oncology Inc’s current trading price is -3.47% away from its 52-week high, while its distance from the 52-week low is 522.34%. The stock’s price range during this period has spanned from $0.94 to $6.06. In the Healthcare sector, the

Industry

Cardiff Oncology Inc: Analyzing CRDF Stock Trends

Cardiff Oncology Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $6.06 on 03/14/24, and the lowest price during the same period was recorded at $0.94 on 11/10/23. 52-week price history of CRDF Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Cardiff Oncology Inc’s current trading price is -19.64% away from its 52-week high, while its distance from the 52-week low is 418.09%. The stock’s price range for this period has remained between $0.94

VIPS stock
Industry

Cardiff Oncology Inc (CRDF) Stock: A Comprehensive 52-Week Review

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Cardiff Oncology Inc’s current trading price is 0.49% away from its 52-week high, while its distance from the 52-week low is 340.43%. The stock’s price range over this period has fluctuated between $0.94 and $4.12. The company, operating within the financial sector, had a trading volume of approximately 1.81 million for the day, which was noticeably higher than the average daily share volume of 1.26 million over the last 3 months. In terms of market performance, Cardiff

News

Cardiff Oncology Inc Inc. (CRDF) Price Performance: The Role of Share Buybacks and Stock Splits

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price gain of 135.81% this year. Over the last six months, there has been a weaker performance of 89.67%. The price of CRDF fallen by 115.43% during the last 30 days period. For the last 5-days stocks have improved 104.09%. Cardiff Oncology Inc’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $3.07 on 03/04/24, with the lowest value being $0.94 on

PNC Stock
News

Cardiff Oncology Inc’s: Contrasting Stock Performances in a Volatile Market

The market performance of Cardiff Oncology Inc has been somewhat stable. Over the past year, the company’s stock achieved a high of $2.79 on 08/08/23, with the lowest value for the same timeframe being $0.94, recorded on 11/10/23. 52-week price history of CRDF Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Cardiff Oncology Inc’s current trading price is -11.50% away from its 52-week high, while its distance from the 52-week low is 162.67%. The stock’s price range for this period has